Ambient AI Clinical Trial

This is a single-site pragmatic randomized control trial studying the effect of ambient artificial intelligence (AI) scribes on the delivery of medical care to patients in the ambulatory setting. The study will last 150 days and include up to 65 providers in the intervention group. Providers will be recruited from three medical specialties, including primary care, oncology, and urology. The study will enroll providers and randomize them to an intervention group (access to the ambient AI scribe product) or a control group (routine patient care). Providers will be evaluated for burnout and task load measures through digital surveys at the beginning, middle, and end of the study. Provider electronic health record (EHR) usage data will also be evaluated for time spent documenting, time spent after hours on days with scheduled clinical care, and time between the start of the clinical encounter and signing it.

NCT Number	NCT07598721
Lead Sponsor	University of Washington
Conditions	Artificial Intelligence (AI), Physician Burnout, Physician Work Environment
Enrollment	139 participants
Start Date	2024-12-19
Primary Completion	2025-07-04 (estimated)
Study Completion	2025-07-04 (estimated)
Updated on ClinicalTrials.gov	2026-05-28